Report cover image

Global Induced Pluripotent Stem Cells Market

Publisher Coherent Market Insights
Published Jul 11, 2025
Length 164 Pages
SKU # CMI20303021

Description

Induced pluripotent stem cells (iPSCs) are a type of pluripotent stem cell that can be generated directly from adult cells. The discovery of induced pluripotent stem cells revolutionized the field of regenerative medicine as it provided an ethically superior alternative to embryonic stem cells. Induced pluripotent stem cells (iPSCs) are adult cells that have been genetically reprogrammed to an embryonic stem cell-like pluripotent state. iPSCs are used in regenerative medicine research to study mechanisms of disease and for drug discovery and toxicity screening. Regenerative properties of iPSCs provide opportunities for developing cell-based therapies. These cells are reprogrammed from their original differentiated adult cells through the introduction or overexpression of key transcription factors that enable them to regress to a state that resembles embryonic stem cells in terms of differentiation potential and expression of pluripotency markers. This technology holds tremendous promise for developing patient and disease specific stem cell models for drug discovery, toxicity screening, and regenerative therapies.

Market Dynamics

Global induced pluripotent stem cells market is driven by rising prevalence of chronic diseases, increasing adoption of organ transplantation and growing research and development (R&D) investments by biopharmaceutical companies for developing novel stem cell-based therapies. However, high costs that are associated with iPSC research and clinical applications, technical challenges in cell reprogramming and stem cell differentiation are restraining wider market growth. Meanwhile, ongoing advancements in stem cell technologies including establishment of standard culture practices, development of xeno-free reprogramming methods and progress in large-scale stem cell production are expected to offer lucrative growth opportunities for market players.

Key features of the study
  • This report provides an in-depth analysis of the global induced pluripotent stem cells market, and provides market size (USD Mn) and compound annual growth rate (CAGR %) for the forecast period (2025-2032), considering 2024 as the base year.
  • It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global induced pluripotent stem cells market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
  • The key companies covered as a part of this study include Takara Bio Inc., Thermo Fisher Scientific, Fujifilm Holdings Corporation, Astellas Pharma, Fate Therapeutics, Ncardia, ViaCyte, Cellular Dynamics International, Lonza, Blueprint Medicines, and Other Prominent Players.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • Global induced pluripotent stem cells market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global induced pluripotent stem cells market.
Market Segmentation
  • By Cell Source
  • Skin derived iPSCs
  • Blood derived iPSCs
  • Urine Derived iPSCs
  • Hepatocytes derived iPSCs
  • Lung fibroblast derived iPSCs
  • Others (Endothelial cells, Glial Cells, Adipose stem cells etc.)
  • By Application
  • Culture & Maintenance
  • Differentiation
  • Genetic Manipulation & Engineering
  • Characterization & Validation
  • Banking & Storage
  • Others (Reprogramming kits, Analysis software etc.)
  • By End User
  • Hospitals
  • Diagnostics Centers
  • Pharmaceutical & Biotechnology Companies
  • Contract Research Organizations
  • Others (Academic & Research Institutes etc.)
  • By Region
  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
  • South Africa
  • North Africa
  • Central Africa
  • Top Companies in the Global Induced Pluripotent Stem Cells Market
  • Takara Bio Inc.
  • Thermo Fisher Scientific
  • Fujifilm Holdings Corporation
  • Astellas Pharma
  • Fate Therapeutics
  • Ncardia
  • ViaCyte
  • Cellular Dynamics International
  • Lonza
  • Blueprint Medicines
  • Other Prominent Players

Table of Contents

164 Pages
1. Research Objectives and Assumptions
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Global Induced Pluripotent Stem Cells Market Snippet, By Cell Source
Global Induced Pluripotent Stem Cells Market Snippet, By Application
Global Induced Pluripotent Stem Cells Market Snippet, By End User
Global Induced Pluripotent Stem Cells Market Snippet, By Region
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Drivers
Restraints
Opportunities
Key Highlights
Regulatory Scenario
Recent Trends
Product Launches/Approvals
PEST Analysis
PORTER’s Analysis
Mergers, Acquisitions, and Collaborations
4. Global Induced Pluripotent Stem Cells Market, By Cell Source, 2020-2032, (USD Mn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021 - 2032
Segment Trends
Skin derived iPSCs
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(USD Mn)
Blood derived iPSCs
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(USD Mn)
Urine Derived iPSCs
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(USD Mn)
Hepatocytes derived iPSCs
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(USD Mn)
Lung fibroblast derived iPSCs
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(USD Mn)
Others (Endothelial cells, Glial Cells, Adipose stem cells etc.)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(USD Mn)
5. Global Induced Pluripotent Stem Cells Market, By Application, 2020-2032, (USD Mn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021 - 2032
Segment Trends
Culture & Maintenance
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(USD Mn)
Differentiation
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(USD Mn)
Genetic Manipulation & Engineering
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(USD Mn)
Characterization & Validation
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(USD Mn)
Banking & Storage
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(USD Mn)
Others (Reprogramming kits, Analysis software etc.)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(USD Mn)
6. Global Induced Pluripotent Stem Cells Market, By End User, 2020-2032, (USD Mn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2020 – 2032
Segment Trends
Hospitals
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(USD Mn)
Diagnostics Centers
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(USD Mn)
Pharmaceutical & Biotechnology Companies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(USD Mn)
Contract Research Organizations
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(USD Mn)
Others (Academic & Research Institutes etc.)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(USD Mn)
7. Global Induced Pluripotent Stem Cells Market, By Region, 2020-2032, (USD Mn)
Introduction
Market Share Analysis, By Region, 2025 and 2032 (%)
Y-o-Y Growth Analysis, For Region, 2021 - 2032
Country Trends
North America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Cell Source, 2020-2032,(USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(USD Mn)
U.S.
Canada
Latin America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Cell Source, 2020-2032,(USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(USD Mn)
Brazil
Argentina
Mexico
Rest of Latin America
Europe
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Cell Source, 2020-2032,(USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(USD Mn)
Germany
U.K.
Spain
France
Italy
Russia
Rest of Europe
Asia Pacific
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Cell Source, 2020-2032,(USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(USD Mn)
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Cell Source, 2020-2032,(USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(USD Mn)
GCC Countries
Israel
Rest of Middle East
Africa
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Cell Source, 2020-2032,(USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020-2032,(USD Mn)
South Africa
North Africa
Central Africa
8. Competitive Landscape
Company Profile
Takara Bio Inc.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Thermo Fisher Scientific
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Fujifilm Holdings Corporation
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Astellas Pharma
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Fate Therapeutics
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Ncardia
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
ViaCyte
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Cellular Dynamics International
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Lonza
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Blueprint Medicines
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Other Prominent Players
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Analyst Views
9. Section
References
Research Methodology
About us

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us